EUVIMEDEUVIMED entdecken
Crossref

Fabrication and Evaluation of PLGA Microsphere-Loaded Hydrogels as Potential Intraocular Lens for Sustained Release of Timolol Maleate

Shahid Iqbal Mir, Yethmini Senadheera, Debrupa Lahiri iD, Prateek K Jha iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Shahid Iqbal Mir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand 247667, India. Hauptthemen laut MEDLINE: Timolol, Polylactic Acid-Polyglycolic Acid Copolymer, Hydrogels, Lenses, Intraocular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eye drops suffer from challenges primarily associated with fast tear clearance, resulting in poor drug bioavailability. We developed a drug-eluting intraocular lens (IOL) that ensures a sustained release of timolol (maleate) as an antiglaucoma agent, for extended periods. Biodegradable poly(lactic-co-glycolic acid) (PLGA) microspheres encapsulated with timolol are first synthesized using the water-in-oil-in-water (w/o/w) double emulsion method. These drug-loaded microspheres are incorporated into poly(acrylamide-sodium acrylate) hydrogel (PAH) IOL cast from a 3D-printed mold, which is then monitored for sustained drug release for an extended period. Developed drug-loaded IOLs are transparent and flexible and demonstrate sustained release of timolol for over 7 weeks. This release duration is drastically higher than direct drug loading in the PAH film, i.e., the degradation control of drug release is much more efficient than drug transport by diffusion alone. Moreover, the incorporation of PLGA microspheres into the PAH film slows PLGA degradation, resulting in a 3-fold increase in release duration when compared to that of standalone microspheres. The resulting system ensures a long-term, patient-friendly approach to glaucoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TimololPolylactic Acid-Polyglycolic Acid CopolymerHydrogelsLenses, IntraocularLactic AcidPolyglycolic AcidMicrospheresDelayed-Action PreparationsDrug LiberationDrug Delivery SystemsHumans

Stichwörter der Autor:innen

3D printingbiodegradablecataractglaucomahydrogelintraocular lens (IOL)ocular drug deliverysustained drug releasetimolol

Substanzen

TimololPolylactic Acid-Polyglycolic Acid CopolymerHydrogelsDelayed-Action PreparationsLactic AcidPolyglycolic Acid

Autor:innen und Institutionen

  • Department of Chemical Engineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand 247667, India.
  • Biomaterials and Multiscale Mechanics Lab, Department of Metallurgical and Materials Engineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
  • Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, India.

ORCID-Profile: Debrupa Lahiri, Prateek K Jha

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Mir, S. I., Senadheera, Y., Lahiri, D., & Jha, P. K. (2026). Fabrication and Evaluation of PLGA Microsphere-Loaded Hydrogels as Potential Intraocular Lens for Sustained Release of Timolol Maleate. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01161

Vancouver

Mir SI, Senadheera Y, Lahiri D, Jha PK. Fabrication and Evaluation of PLGA Microsphere-Loaded Hydrogels as Potential Intraocular Lens for Sustained Release of Timolol Maleate. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01161

BibTeX
@article{Mir2026,
  author = {Mir, Shahid Iqbal and Senadheera, Yethmini and Lahiri, Debrupa and Jha, Prateek K},
  title = {Fabrication and Evaluation of PLGA Microsphere-Loaded Hydrogels as Potential Intraocular Lens for Sustained Release of Timolol Maleate},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01161}
}
Kostenlos starten →